Mohammad A Alfhili
Overview
Explore the profile of Mohammad A Alfhili including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
361
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Alfhili M, Alsughayyir J
Toxicon
. 2024 Feb;
240:107636.
PMID: 38316294
Ample evidence indicates that bufalin (BFN), a cardiotonic steroid in Bufo toad toxin, possesses a potent anticancer activity mainly by stimulating apoptosis in cancer cells. Human red blood cells (RBCs)...
12.
Almuqrin A, Alshuweishi Y, Alfaifi M, Daghistani H, Al-Sheikh Y, Alfhili M
Ann Saudi Med
. 2024 Feb;
44(1):18-25.
PMID: 38311853
Background: Hyperuricemia is linked to an increased risk of various chronic diseases, but data on the prevalence and association of hyperuricemia with liver function in Saudi Arabia are scarce. Objectives:...
13.
Alghareeb S, Alsughayyir J, Alfhili M
Pharmaceuticals (Basel)
. 2023 Dec;
16(12).
PMID: 38139808
Background: Hemolysis and eryptosis result in the premature elimination of circulating erythrocytes and thus contribute to chemotherapy-related anemia, which is extremely prevalent in cancer patients. Eriocitrin (ERN), a flavanone glycoside...
14.
Alghareeb S, Alfhili M, Alsughayyir J
Molecules
. 2023 Dec;
28(24).
PMID: 38138543
Background: Rosmarinic acid (RA) possesses promising anticancer potential, but further development of chemotherapeutic agents is hindered by their toxicity to off-target tissue. In particular, chemotherapy-related anemia is a major obstacle...
15.
Alghareeb S, Alfhili M, Alsughayyir J
Life (Basel)
. 2023 Dec;
13(12).
PMID: 38137900
Background: Eryptosis stimulated by anticancer drugs can lead to anemia in patients. β-caryophyllene oxide (CPO) is an anticancer sesquiterpene present in various plants; however, its effect on the structure and...
16.
Basudan A, Basuwdan A, Abudawood M, Farzan R, Alfhili M
Life (Basel)
. 2023 Nov;
13(11).
PMID: 38004338
Colorectal cancer (CRC) is the commonest cancer in Saudi males and the third most common in Saudi females. Although CRC represents a major public health challenge, the resources to evaluate...
17.
Alshuweishi Y, Basudan A, Alfaifi M, Daghistani H, Alfhili M
Medicina (Kaunas)
. 2023 Nov;
59(11).
PMID: 38004051
: Dyslipidemia is a major risk factor for cardiovascular disease (CVD). The identification of new biomarkers that may enhance the risk assessment of lipid abnormalities is a promising approach in...
18.
Alfhili M, Alyousef A, Alsughayyir J
Med Oncol
. 2023 Oct;
40(11):333.
PMID: 37848569
Chemotherapy-related anemia is a major obstacle in anticancer therapy. Tamoxifen (TAM) is an antiestrogen prescribed for breast cancer patients with hemolytic potential and apoptotic properties in nucleated cells. However, the...
19.
Alghareeb S, Alsughayyir J, Alfhili M
Molecules
. 2023 Sep;
28(18).
PMID: 37764276
Background: Chemotherapy-related anemia is prevalent in up to 75% of patients, which may arise due to hemolysis and eryptosis. Alpha-mangostin (α-MG) is a polyphenolic xanthonoid found in the mangosteen tree...
20.
Alshuweishi Y, Alfaifi M, Almoghrabi Y, Al-Sheikh Y, Alfhili M
Medicina (Kaunas)
. 2023 Sep;
59(9).
PMID: 37763711
: The link between inflammation and anemia is well established but fluctuations in the emerging inflammatory index, neutrophil-lymphocyte ratio (NLR), in anemic subjects remain ambiguous. The purpose of this study...